Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy and immunotherapy.

C McKinnon1

  • 1Current Drugs Ltd, Middlesex House, 34-42 Cleveland Street, London, W1P 6LB, UK. colinm@cursci.co.uk

Idrugs : the Investigational Drugs Journal
|August 30, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disruption of Transthalamic Circuitry from the Primary Visual Cortex Impairs Visual Discrimination in Mice.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2025
Same author

DISRUPTION OF TRANSTHALAMIC CIRCUITRY FROM PRIMARY VISUAL CORTEX IMPAIRS VISUAL DISCRIMINATION IN MICE.

bioRxiv : the preprint server for biology·2025
Same author

A transthalamic pathway crucial for perception.

bioRxiv : the preprint server for biology·2023
Same author

A feline anaesthetic death associated with equipment incompatibility.

Australian veterinary journal·2019
Same author

Qualitative results of a structured group program for carers of people with frontotemporal dementia.

International journal of geriatric psychiatry·2013
Same author

Clinical evaluation of alfaxalone as an anaesthetic induction agent in cats less than 12 weeks of age.

Australian veterinary journal·2012
Same journal

Filibuvir, a non-nucleoside NS5B polymerase inhibitor for the potential oral treatment of chronic HCV infection.

IDrugs : the investigational drugs journal·2010
Same journal

Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures.

IDrugs : the investigational drugs journal·2010
Same journal

LX-1031, a tryptophan 5-hydroxylase inhibitor that reduces 5-HT levels for the potential treatment of irritable bowel syndrome.

IDrugs : the investigational drugs journal·2010
Same journal

Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis.

IDrugs : the investigational drugs journal·2010
Same journal

Lu-AA21004, a multimodal serotonergic agent, for the potential treatment of depression and anxiety.

IDrugs : the investigational drugs journal·2010
Same journal

Florbetapir (18F), a PET imaging agent that binds to amyloid plaques for the potential detection of Alzheimer's disease.

IDrugs : the investigational drugs journal·2010
See all related articles

The 35th annual meeting of the American Society of Clinical Oncology showcased advancements in cancer research. Key topics included gene therapy, immunotherapy, and novel treatments for prostate cancer.

Area of Science:

  • Oncology
  • Cancer Research
  • Medical Conferences

Background:

  • The American Society of Clinical Oncology (ASCO) holds an influential annual meeting for cancer professionals.
  • The 35th annual meeting convened a large global audience of cancer experts.
  • The event serves as a critical forum for disseminating the latest research and clinical findings.

Purpose of the Study:

  • To summarize the key themes and discussions from the 35th annual ASCO meeting.
  • To highlight emerging trends and significant advancements in cancer therapy and research presented at the conference.
  • To provide an overview of the diverse scientific program and its focus areas.

Main Methods:

  • The content is based on the program and reported highlights of the 35th ASCO annual meeting.

Related Experiment Videos

  • Information was gathered from sessions including poster presentations, oral abstracts, and symposia.
  • Keynote lectures and 'meet the professor' sessions also contributed to the identified topics.

    • Main Results:

    • The meeting covered a wide range of oncological disciplines and therapeutic modalities.
    • Significant focus was placed on innovative treatments such as gene therapy, immunotherapy, and biological therapies (vaccines, antibodies).
    • Specific attention was given to prostate cancer, signal transduction inhibitors, and anti-angiogenesis agents.

    Conclusions:

    • The 35th ASCO meeting underscored the rapid progress in cancer treatment and research.
    • Emerging therapies and a deeper understanding of cancer biology are driving new clinical approaches.
    • The conference highlighted a multidisciplinary effort to combat cancer through novel strategies and collaborative research.